ADAMTS17

ADAM metallopeptidase with thrombospondin type 1 motif 17, the group of ADAM metallopeptidases with thrombospondin type 1 motif

Basic information

Region (hg38): 15:99971437-100342005

Links

ENSG00000140470NCBI:170691OMIM:607511HGNC:17109Uniprot:Q8TE56AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Weill-Marchesani 4 syndrome, recessive (Moderate), mode of inheritance: AR
  • Weill-Marchesani 4 syndrome, recessive (Strong), mode of inheritance: AR
  • Weill-Marchesani 4 syndrome, recessive (Supportive), mode of inheritance: AR
  • Weill-Marchesani 4 syndrome, recessive (Definitive), mode of inheritance: AR
  • Weill-Marchesani 4 syndrome, recessive (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Weill-Marchesan syndrome 4AROphthalmologic; PharmacogenomicIndividuals may be at risk of glaucoma, and surveillance may allow early management and preventive measures; Agents that may contribute to glaucoma should be avoidedMusculoskeletal; Ophthalmologic19836009; 20375329; 22486325

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ADAMTS17 gene.

  • not_provided (917 variants)
  • Inborn_genetic_diseases (204 variants)
  • Weill-Marchesani_4_syndrome,_recessive (156 variants)
  • ADAMTS17-related_disorder (20 variants)
  • not_specified (1 variants)
  • Anterior_segment_dysgenesis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAMTS17 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000139057.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
10
clinvar
319
clinvar
11
clinvar
341
missense
1
clinvar
4
clinvar
425
clinvar
19
clinvar
4
clinvar
453
nonsense
16
clinvar
2
clinvar
1
clinvar
19
start loss
0
frameshift
18
clinvar
3
clinvar
2
clinvar
23
splice donor/acceptor (+/-2bp)
2
clinvar
11
clinvar
2
clinvar
15
Total 37 21 440 338 15

Highest pathogenic variant AF is 0.0000483364

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ADAMTS17protein_codingprotein_codingENST00000268070 22370417
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.80e-151.001256741731257480.000294
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.397286301.160.00004347044
Missense in Polyphen337307.361.09643444
Synonymous-4.693722731.360.00002152186
Loss of Function3.283461.90.5490.00000368635

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007210.000691
Ashkenazi Jewish0.000.00
East Asian0.0003810.000381
Finnish0.00004620.0000462
European (Non-Finnish)0.0003820.000378
Middle Eastern0.0003810.000381
South Asian0.0002650.000229
Other0.000.00

dbNSFP

Source: dbNSFP

Disease
DISEASE: Weill-Marchesani syndrome 4 (WMS4) [MIM:613195]: An autosomal recessive syndrome characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia and short stature. Brachydactyly and decreased joint flexibility are present in some patients. {ECO:0000269|PubMed:19836009, ECO:0000269|PubMed:22486325, ECO:0000269|PubMed:24940034}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Post-translational protein modification;Metabolism of proteins;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation (Consensus)

Recessive Scores

pRec
0.124

Intolerance Scores

loftool
0.514
rvis_EVS
-2.27
rvis_percentile_EVS
1.26

Haploinsufficiency Scores

pHI
0.247
hipred
Y
hipred_score
0.544
ghis
0.479

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.382

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerHighMediumHigh

Mouse Genome Informatics

Gene name
Adamts17
Phenotype

Gene ontology

Biological process
proteolysis
Cellular component
extracellular region
Molecular function
nucleic acid binding;metalloendopeptidase activity;metal ion binding